Amplia Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	59	121	27	15	16	28
Market Cap Growth	204.32%	343.99%	81.79%	-9.41%	-41.33%	0.13%
Enterprise Value	32	92	23	12	7	25
Last Close Price	0.12	0.23	0.07	0.07	0.08	0.14
PS Ratio	12.32	25.17	7.18	3.36	13.86	14.17
PB Ratio	1.50	3.06	1.29	1.31	1.04	1.29
P/TBV Ratio	1.87	3.82	2.08	4.29	2.09	2.02
EV/Sales Ratio	6.58	19.16	5.99	2.59	5.99	12.57
Debt / Equity Ratio	0.01	0.01	0.00	0.14	0.14	0.10
Net Debt / Equity Ratio	-0.70	-0.70	-0.52	-0.16	-0.44	-0.57
Net Debt / EBITDA Ratio	3.29	3.29	1.60	0.39	1.11	3.44
Net Debt / FCF Ratio	3.14	3.14	1.58	0.35	1.32	2.83
Asset Turnover	0.15	0.15	0.20	0.27	0.06	0.11
Quick Ratio	19.54	19.54	7.75	1.93	3.78	31.03
Current Ratio	19.78	19.78	7.91	1.98	3.82	31.18
Return on Equity (ROE)	-25.48%	-25.48%	-40.51%	-33.05%	-33.13%	-22.64%
Return on Assets (ROA)	-16.29%	-16.29%	-22.47%	-17.04%	-18.20%	-12.88%
Return on Capital Employed (ROCE)	-21.10%	-21.10%	-32.30%	-39.90%	-39.40%	-15.20%
Earnings Yield	-13.06%	-6.39%	-24.20%	-30.15%	-37.85%	-12.96%
FCF Yield	-14.85%	-7.27%	-25.36%	-34.34%	-32.18%	-15.71%
Buyback Yield / Dilution	-52.88%	-52.88%	-58.35%	-0.02%	-33.27%	-53.71%